Round Rock Advisors LLC Makes New Investment in CVS Health Co. (NYSE:CVS)

Round Rock Advisors LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 40,390 shares of the pharmacy operator's stock, valued at approximately $3,189,000. CVS Health comprises 0.8% of Round Rock Advisors LLC's investment portfolio, making the stock its 28th largest holding.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in CVS Health by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator's stock valued at $8,180,295,000 after buying an additional 485,744 shares during the last quarter. Morgan Stanley grew its stake in CVS Health by 10.9% in the 4th quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator's stock valued at $3,128,984,000 after buying an additional 3,311,928 shares during the last quarter. FMR LLC grew its stake in CVS Health by 29.1% in the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator's stock valued at $1,919,159,000 after buying an additional 6,194,441 shares during the last quarter. Moneta Group Investment Advisors LLC grew its stake in CVS Health by 103,371.0% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator's stock valued at $1,448,877,000 after buying an additional 15,532,533 shares during the last quarter. Finally, Norges Bank bought a new stake in CVS Health in the 4th quarter valued at about $1,425,416,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on CVS shares. SVB Leerink started coverage on shares of CVS Health in a report on Monday, February 26th. They issued an "outperform" rating and a $88.00 price objective for the company. Barclays started coverage on shares of CVS Health in a report on Wednesday, March 6th. They issued an "equal weight" rating and a $78.00 price objective for the company. Piper Sandler upped their price target on shares of CVS Health from $93.00 to $94.00 and gave the stock an "overweight" rating in a report on Friday, March 15th. Leerink Partnrs reaffirmed an "outperform" rating on shares of CVS Health in a report on Monday, February 26th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $87.00 price target on shares of CVS Health in a report on Wednesday. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $89.44.

Insider Transactions at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company's stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.25% of the stock is currently owned by corporate insiders.

CVS Health Trading Down 2.0 %

NYSE CVS traded down $1.41 on Thursday, hitting $69.74. The company's stock had a trading volume of 10,416,596 shares, compared to its average volume of 11,062,846. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25. The company's 50-day moving average is $76.02 and its 200 day moving average is $73.79. The firm has a market cap of $87.91 billion, a PE ratio of 11.01, a PEG ratio of 0.98 and a beta of 0.52.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion during the quarter, compared to analysts' expectations of $90.58 billion. During the same period in the prior year, the company posted $1.99 EPS. The company's revenue was up 11.9% on a year-over-year basis. As a group, analysts predict that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.81%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health's dividend payout ratio (DPR) is presently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.